Verastem, Inc.

NasdaqCM:VSTM Stock Report

Market Cap: US$821.2m

Verastem Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

NasdaqCM:VSTM Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
03 Nov 25SellUS$12,146Daniel PatersonIndividual1,299US$9.35
24 Sep 25SellUS$748Daniel CalkinsIndividual82US$9.23
16 Sep 25SellUS$5,864Brian StuglikIndividual587US$9.99
16 Sep 25SellUS$2,807Robert GagnonIndividual281US$9.99
16 Sep 25SellUS$3,896Daniel PatersonIndividual390US$9.99
06 Aug 25SellUS$7,739Daniel PatersonIndividual1,332US$5.81
23 Jun 25SellUS$21,202Daniel CalkinsIndividual4,135US$5.13
20 Jun 25SellUS$91,355Daniel PatersonIndividual17,808US$5.13
16 Jun 25SellUS$1,605Robert GagnonIndividual284US$5.65
16 Jun 25SellUS$1,893Daniel PatersonIndividual335US$5.65
16 Jun 25SellUS$3,356Brian StuglikIndividual594US$5.65
20 May 25SellUS$477,044Daniel PatersonIndividual58,677US$8.13
20 May 25SellUS$90,593Daniel CalkinsIndividual11,143US$8.13
05 May 25SellUS$5,986Daniel PatersonIndividual820US$7.30
24 Mar 25SellUS$631Daniel CalkinsIndividual91US$7.04
17 Mar 25SellUS$4,121Brian StuglikIndividual593US$6.95
17 Mar 25SellUS$1,696Daniel PatersonIndividual244US$6.95
17 Mar 25SellUS$1,974Robert GagnonIndividual284US$6.95
04 Feb 25SellUS$4,891Daniel PatersonIndividual858US$5.70
13 Jan 25SellUS$44,896Daniel PatersonIndividual8,568US$5.24
06 Jan 25SellUS$42Daniel CalkinsIndividual6US$6.94
24 Dec 24SellUS$392Daniel CalkinsIndividual93US$4.34
19 Dec 24SellUS$4,161Brian StuglikIndividual929US$4.54
19 Dec 24SellUS$1,907Daniel PatersonIndividual427US$4.54
19 Dec 24SellUS$1,862Robert GagnonIndividual415US$4.54

Insider Trading Volume

Insider Buying: VSTM insiders have only sold shares in the past 3 months.

Ownership Breakdown

What is the ownership structure of VSTM?
Owner TypeNumber of SharesOwnership Percentage
Individual Insiders429,7410.557%
General Public12,682,75116.4%
Hedge Funds17,502,43222.7%
Institutions46,566,94560.3%

Dilution of Shares: Shareholders have been substantially diluted in the past year, with total shares outstanding growing by 73.4%.

Top Shareholders

Top 25 shareholders own 72.09% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
7.03%
RTW Investments, LP
5,426,306US$57.7m27.6%0.57%
5.37%
Balyasny Asset Management L.P.
4,146,762US$44.1m-1.41%0.09%
5.25%
Logos Global Management, L.P.
4,050,000US$43.1m305%3.09%
5.03%
Point72 Asset Management, L.P.
3,879,364US$41.3m0%0.07%
4.99%
Deep Track Capital, LP
3,849,390US$41.0m0%0.76%
4.82%
BlackRock, Inc.
3,717,182US$39.6m34.7%no data
4.51%
The Vanguard Group, Inc.
3,479,011US$37.0m1.62%no data
4.06%
Foresite Capital Management, LLC
3,135,120US$33.4m19.9%4.57%
3.46%
Stonepine Capital Management LLC
2,670,032US$28.4m96.3%12.49%
3.43%
Vivo Capital, LLC
2,644,985US$28.1m71.9%1.41%
2.89%
State Street Global Advisors, Inc.
2,228,640US$23.7m-1.01%no data
2.72%
Armistice Capital LLC
2,096,000US$22.3m-1.87%0.57%
2.5%
Rosalind Advisors, Inc.
1,929,563US$20.5m-5.58%6.72%
2.01%
Morgan Stanley
1,550,625US$16.5m42.2%no data
1.68%
Nantahala Capital Management, LLC
1,292,903US$13.8m-56.2%0.75%
1.61%
Geode Capital Management, LLC
1,244,581US$13.2m3.78%no data
1.5%
Millennium Management LLC
1,159,598US$12.3m2,070%0.01%
1.37%
Polar Capital Holdings Plc
1,058,776US$11.3m5.88%0.03%
1.37%
Marshall Wace LLP
1,055,389US$11.2m293%0.01%
1.35%
Silverarc Capital Management, LLC
1,042,757US$11.1m0%1.22%
1.21%
Soleus Capital Management, L.P.
935,909US$10.0m0%0.37%
1.15%
OrbiMed Advisors LLC
887,561US$9.4m0%0.12%
1.02%
Tang Capital Management, LLC
789,810US$8.4m193%0.25%
1.01%
Acorn Bioventures
779,498US$8.3m0%3.03%
0.76%
Jefferies Financial Group Inc.
590,184US$6.3m48.4%0.05%

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/11/28 16:51
End of Day Share Price 2025/11/28 00:00
Earnings2025/09/30
Annual Earnings2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Verastem, Inc. is covered by 27 analysts. 9 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Matthew CrossAlliance Global Partners
James MolloyAlliance Global Partners
Kalpit PatelB. Riley Securities, Inc.